Summary Deciphera Pharmaceuticals LLC (Deciphera Pharmaceuticals) is a research and development company that develops, designs, and commercializes kinase inhibiting drugs. The company's clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It uses proprietary switch control inhibitor platform for discovering and developing kinase inhibitors. Deciphera Pharmaceuticals products are used in the treatment of renal and colon cancers, mastocytosis, gastrointestinal stromal tumors, crohn’s disease and autoimmune nephritis, solid tumors, rheumatoid arthritis, and others. The company's products are used in the treatment of immunological diseases and cancers. It sells its products through medical representatives. Deciphera Pharmaceuticals is headquartered in Waltham, Massachusetts, the US. Deciphera Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their... Research Beam Model: Research Beam Product ID: 1916025 250 USD New
Deciphera Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Deciphera Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 23
  • Publisher : GlobalData
 
 
 
Summary

Deciphera Pharmaceuticals LLC (Deciphera Pharmaceuticals) is a research and development company that develops, designs, and commercializes kinase inhibiting drugs. The company's clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It uses proprietary switch control inhibitor platform for discovering and developing kinase inhibitors. Deciphera Pharmaceuticals products are used in the treatment of renal and colon cancers, mastocytosis, gastrointestinal stromal tumors, crohn’s disease and autoimmune nephritis, solid tumors, rheumatoid arthritis, and others. The company's products are used in the treatment of immunological diseases and cancers. It sells its products through medical representatives. Deciphera Pharmaceuticals is headquartered in Waltham, Massachusetts, the US.

Deciphera Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Deciphera Pharma Raises USD52 Million in series C Financing 10
Deciphera Pharma Raises USD15 Million in Extended Series B Financing 11
Deciphera Pharma Raises USD75 Million in Series B Financing Round 11
Deciphera Pharma Raises USD21.5 Million in Financing Round 12
Deciphera Pharma Raises USD90.6 Million in Financing Round 13
Partnerships 13
Emerald Biostructures Extends Research Agreement With Deciphera Pharma 13
Licensing Agreements 14
Deciphera Pharma Extends Its Licensing Agreement With Eli Lilly and Company 14
Deciphera Pharmaceuticals LLC - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Product News 19
Oct 31, 2016: Deciphera Pharmaceuticals to Present Clinical Data on Altiratinib at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics 19
Clinical Trials 20
Apr 20, 2016: Deciphera’s Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, Demonstrates Potent Macrophage Checkpoint Inhibition as a Single Agent and In Combination with an Anti-PD1 Inhibitor 20
Mar 21, 2016: Deciphera Pharmaceuticals Announces Study Results for Altiratinib Demonstrating Inhibition of Tumor Growth and Invasiveness in Glioblastoma 21
Mar 17, 2016: Deciphera Pharmaceuticals to Present Data on its Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, at American Association for Cancer Research Annual Meeting 2016 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 1
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Deciphera Pharmaceuticals LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Deciphera Pharma Raises USD52 Million in series C Financing 10
Deciphera Pharma Raises USD15 Million in Extended Series B Financing 11
Deciphera Pharma Raises USD75 Million in Series B Financing Round 11
Deciphera Pharma Raises USD21.5 Million in Financing Round 12
Deciphera Pharma Raises USD90.6 Million in Financing Round 13
Emerald Biostructures Extends Research Agreement With Deciphera Pharma 13
Deciphera Pharma Extends Its Licensing Agreement With Eli Lilly and Company 14
Deciphera Pharmaceuticals LLC, Key Competitors 16
Deciphera Pharmaceuticals LLC, Key Employees 17
Deciphera Pharmaceuticals LLC, Other Locations 18List of Figures
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Deciphera Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter